Navigation Links
Protein's role in regulating cell death sets direction for cancer research

A protein called calpain can be the key either preventing or promoting the cell death, a Queen's University study has found.

"This work provides proof in principle that pharmacological inhibition of calpain may be used to block cell death in situations where this is not desirable, such as in neuronal cells of Alzheimer's or Parkinson's patients, but to promote cell death in cancer cells where this is clearly a very desirable outcome," says lead researcher Peter Greer of two studies appearing in the Journal of Biological Chemistry (JBC).

Dr. Greer is a Professor of Pathology and Molecular Medicine with the Cancer Biology and Genetics division of Queen's University's Cancer Research Institute.

"All cells in our body have the ability to trigger an intrinsic programmed cell death response. In the case of nerve cells that have been temporarily cut off from their oxygen supply because of a stroke, or damaged by amyloid deposits, this might seem like a bad thing that could contribute to neurodegenerative disease," says Dr. Greer who produced the study with Yinfei Tan, Nathalie Dourdin, Chao Wu, Teresa De Veyra, and John S. Elce.

"On the other hand, when a cell's chromosomes are damaged by carcinogens or ultraviolet light in a way that could initiate cancer, this same programmed cell death response could save your life."

Supported by an operating grant from the Canadian Institute of Health Research the first study, published online and to appear in print on June 9, showed that calpain promoted programmed cell death after cells were damaged by chemicals that disrupt the endoplasmic reticulum, which is a major synthetic structure in the cell that controls the synthesis and distribution of new proteins.

In the second study, now published in JBC online, Dr. Greer and co-investigators Yinfei Tan, Chao Wu, and Teresa De Veyra, found that calpain also inhibits programmed cell death in response to other challenges, including some chemotherapeutic drugs.

This study showed that calpain contributes to the activation of AKT and JNK, two key players in the signaling pathways that control cellular responses to different death stimuli. These discoveries suggest that calpain inhibitors might improve the ability of chemotherapeutic drugs or radiation treatment to specifically kill tumour cells in cancer patients.


'"/>

Source:Queen's University


Related biology news :

1. A new mechanism of regulating RNA degradation
2. Depression gene may weaken mood-regulating circuit
3. Mechanism regulating tooth shape formulation found
4. Scientists discover new regulating mechanism in cells
5. Combination therapy boosts effectiveness of telomere-directed cancer cell death
6. Enzyme allows B cells to resist death, leading to leukemia
7. Critical role in programmed cell death identified
8. A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020
9. The death of a very special chimpanzee
10. The very unexpected life and death of a leukemic cell
11. Solutions that reduce death of marine life reeled in by International Smart Gear Competition
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/26/2017)... , Jan. 26, 2017  Acuity Market ... for Biometrics and Digital Identity".  Acuity characterizes 2017 ... identity when increased adoption reflects a new understanding ... "Biometrics and digital identity are often ... Maxine Most , Principal of Acuity Market ...
(Date:1/21/2017)... 20, 2017 Research and Markets has announced ... report to their offering. ... The global voice recognition biometrics market to grow ... The report covers the present scenario and the growth prospects ... the market size, the report considers the revenue generated from the ...
(Date:1/13/2017)... WASHINGTON, N.Y. , Jan. 13, 2017 /PRNewswire/ ... of technology solutions for the homecare industry, including ... of homecare industry expert, Justin Jugs, as Senior ... brings more than 15 years of homecare experience ... team in developing strategic plans to align Sandata,s ...
Breaking Biology News(10 mins):
(Date:2/20/2017)... NEW YORK , Feb. 20, 2017  This Report analyzes ... Software, Hardware, and Biocontent. The report provides separate comprehensive analytics for ... , Europe , Asia-Pacific , ... Read the full report: http://www.reportlinker.com/p04707099-summary/view-report.html ... Annual estimates and forecasts ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... success among radiotherapy patients, prevent chest wall collapses in pre-term infants with ... will receive a total of $600,000 in funding through the ninth round ...
(Date:2/19/2017)... ... February 19, 2017 , ... ... OHAUS Corporation ventured outside of weighing equipment with the goal of expanding the ... in mind, the line of Starter water analysis meters were introduced into the ...
(Date:2/17/2017)... According to a new ... Service), Type (Safety, Efficacy, Validation), Disease Indication (Cancer, ... Development, Disease-Risk) - Global Forecast to 2021" published ... USD 53.34 Billion by 2021 from USD 27.95 ... 13.8% during the forecast period (2016-2021). ...
Breaking Biology Technology: